Millions of people have turned to GLP-1 drugs like Ozempic and Wegovy expecting dramatic results. Most get them. But for roughly one in ten patients, the needle barely moves: blood sugar stays ...

Agios Pharmaceuticals, Inc. stock plunged 49% after mixed Phase 3 results for mitapivat in Sickle Cell Disease, raising doubts about future approvals. Mitapivat met the primary hemoglobin endpoint but ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Shares of Altimmune ALT fell 27.04% during market hours on Sep 14, even after the company announced positive top-line results from its 12-week phase I study. The study evaluated pemvidutide in ...

The stock of Dianthus Therapeutics (DNTH) fell in value by ~10% yesterday, as news broke that the French pharma giant Sanofi (SNY) had halted a late-stage study of its candidate riliprubart in ...